CIK 0001001316 · Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363898269
- Phone
- (212) 554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 424B3 Offering Prospectus
- 8-K Event Unregistered share sale
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Other events
- REGDEX/A Other REGDEX/A
- 8-K Event Unregistered share sale
- REGDEX Other REGDEX
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
Page 36 of 58 · 1,151 filings